Nearly one in three gay and bisexual men who were diagnosed with HIV at UK sexual health clinics didn’t meet the criteria for “high risk” that would signal to a clinician that they would be good candidates for pre-exposure prophylaxis (PrEP). And that means that people who appear lower risk may still be good candidates […]
For many people, being told that they are HIV positive is no longer a death sentence. But for Robert Suttle, a Black gay man and social justice educator, it is a life sentence. Unexpectedly caught up in the HIV criminalization web at the age of 30, Suttle spent 6 months in a Louisiana state prison […]
Researchers at the University of North Carolina at Chapel Hill and Duke University improved HIV care by gamifying it with a mobile gaming application. Gaming features—like those used to drive airline loyalty and track daily steps —- helped young men living with HIV achieve viral suppression and doubled their chances for reaching near perfect adherence […]
The COVID-19 pandemic is affecting people with or at risk for HIV both indirectly, by interfering with HIV treatment and prevention services, and directly, by threatening individual health. An effective response to these dual pandemics requires unprecedented collaboration to accelerate basic and clinical research, as well as implementation science to expeditiously introduce evidence-based strategies into […]
Inflammation in the body has been linked to the intensity of tobacco smoking among people with HIV, according to a team of University of Massachusetts Amherst researchers. Krishna Poudel, associate professor of community health education in the School of Public Health and Health Sciences, and colleagues reported positive linear relationships between intensity, duration and pack-years […]
Scientists have identified a group of drugs that may help stop a leading cause of vision loss after making an unexpected discovery that overturns a fundamental belief about DNA. The drugs, known as Nucleoside Reverse Transcriptase Inhibitors, or NRTIs, are commonly used to treat HIV. The new discovery suggests that they may be useful against […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. VALGANCICLOVIR MYLAN contains the active ingredient valganciclovir CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about VALGANCICLOVIR MYLAN tablets. It does not contain all the available information. It does not take the place of talking to […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. VAQTA® Hepatitis A vaccine, Inactivated (hepatitis A virus, inactivated) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about VAQTA.It does not contain all the available information. It does not take the place of talking to your […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. LAMIVUDINE 150 MG + ZIDOVUDINE 300 MG ALPHAPHARM lamivudine and zidovudine CONSUMER MEDICINE INFORMATION What is in this leaflet Please read this leaflet carefully before you start LAMIVUDINE 150mg + ZIDOVUDINE 300mg Alphapharm. This leaflet answers some common questions about LAMIVUDINE 150mg […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. KALIXOCIN clarithromycin CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about Kalixocin. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have […]
